Potential conflict of interest: Dr. Tillmann owns stock in AbbVie, Abbott, and Gilead.
Steatohepatitis/Metabolic Liver Disease
Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease
Version of Record online: 13 DEC 2013
© 2013 by the American Association for the Study of Liver Diseases
Volume 59, Issue 2, pages 471–482, February 2014
How to Cite
Moylan, C. A., Pang, H., Dellinger, A., Suzuki, A., Garrett, M. E., Guy, C. D., Murphy, S. K., Ashley-Koch, A. E., Choi, S. S., Michelotti, G. A., Hampton, D. D., Chen, Y., Tillmann, H. L., Hauser, M. A., Abdelmalek, M. F. and Diehl, A. M. (2014), Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease. Hepatology, 59: 471–482. doi: 10.1002/hep.26661
The majority of this work was supported through an American Recovery and Reinvestment Act (ARRA) grant from the National Institute on Alcohol Abuse and Alcoholism (5RC2 AA019399; A.M.D., principal investigator). Drs. Diehl and Abdelmalek received funding support from the National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK; grant no.: U01-DK57149). Dr. Abdelmalek was supported by a NIH/NIDDK K23 Career Development Award (K23-DK062116).
- Issue online: 29 JAN 2014
- Version of Record online: 13 DEC 2013
- Accepted manuscript online: 2 AUG 2013 06:46AM EST
- Manuscript Accepted: 26 JUL 2013
- Manuscript Received: 26 MAY 2013
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.